Omeprazole 20mg Capsules

Omeprazole 20mg
  • Dosage: Omeprazole 20mg
  • Packaging: 10 capsules/blister*10/box
  • Shelf Life: 36 months 

Click to add this item to cart.

Product Description

Specification & Administration

  • Strength: 20mg per capsule
  • Route: Oral
  • Usage: Take on empty stomach, 30 minutes before meal; swallow whole, do not crush or chew
  • Dosage: Follow doctor’s prescription or professional medical instruction

Indications

  • Gastric ulcer, duodenal ulcer
  • Reflux esophagitis, acid regurgitation and heartburn
  • Chronic gastritis with excessive gastric acid
  • Helicobacter pylori infection combination therapy
  • Zollinger-Ellison syndrome

Product Features & Advantages

  • Classic proton pump inhibitor, strong and long-lasting acid suppression
  • Effectively relieve stomach ache, burning, bloating and acid reflux
  • Protect gastric mucosal lining, promote ulcer healing
  • Fast absorption, stable curative effect, low side effects
  • Standard 20mg dosage, convenient clinical and daily use

Full Product Description

Omeprazole 20mg Capsules belong to Proton Pump Inhibitors (PPI). It inhibits the activity of gastric wall proton pump, blocks the final process of gastric acid secretion, greatly reduces gastric acid volume and gastric acidity.
It accelerates the repair of gastric and duodenal ulcers, relieves symptoms such as acid regurgitation, heartburn and stomach discomfort caused by gastritis and reflux esophagitis. Widely used in gastroenterology clinical treatment, with reliable efficacy and high safety.

Storage & Warnings

Storage Store sealed in a cool dry place, protected from light and moisture.
Warnings
  • Contraindicated in patients with omeprazole or PPI drug allergy.
  • Not suitable for long-term arbitrary use without medical advice.
  • Pregnant, lactating women and liver impaired patients use under medical supervision.
  • Keep out of reach of children.

Omeprazole 20mg Capsules: What the Published Guidance Says

Acid-suppression and antiemetic agents supplied as injectables and orals, including the proton-pump inhibitor and the two antiemetics carried on the WHO Model List.

Omeprazole 20mg Capsules is specified against its own monograph, pack size and market registration, so the guidance below is worth reading together with the GI & Antiemetics range overview.

  • Omeprazole is the listed proton-pump inhibitor Section 17.1 of the Model List carries omeprazole as powder for injection 40 mg in vial, powder for oral liquid, and solid oral dosage forms of 10, 20 and 40 mg, for gastro-oesophageal reflux disease. It was first added in 2009. Therapeutic alternatives are the A02BC proton-pump inhibitor subgroup, excluding combinations. The 2025 revision replaced the 20 mg and 40 mg oral-liquid sachets with 1 mg/mL and 4 mg/mL powders for oral liquid. WHO eEML — Omeprazole
  • A note on ranitidine Ranitidine appears in section 17.1 of the Model List as an antiulcer medicine, with injection, oral liquid and 150 mg tablet presentations. Since 2020 it has been subject to market-level regulatory action in several countries relating to nitrosamine (NDMA) impurities. Confirm current local registration and monograph status before ordering. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
  • Dexamethasone doubles as an antiemetic Dexamethasone injection 4 mg/mL is listed in the antiemetic section as well as under antiallergic and palliative-care medicines — useful context when building a chemotherapy-support or post-operative nausea kit. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)

These points are quoted because they shape how Omeprazole 20mg Capsules is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.

Omeprazole 20mg Capsules — Supply Parameters

Therapeutic groupGI & Antiemetics — GI & Antiemetics
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Ranitidine 150mg Capsules, Cimetidine Injection 2mL:400mg Ampoule, Omeprazole Powder for Injection 40mg, Metoclopramide Injection 10mg/2mL, Ondansetron Injection 4mg/2mL.

Quality Control, Pharmacopoeial Standards & Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Omeprazole 20mg Capsules is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

A typical release panel for this presentation covers:

  • Testing for description and identification
  • Testing for assay of the active substance
  • Testing for related substances and impurities
  • Testing for dissolution or release profile (solid oral forms)
  • Testing for uniformity of dosage units
  • Testing for water content and pH where applicable

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packaging, Labelling & Export

  • Pack size: 10 capsules/blister*10/box. Non-standard pack sizes can be quoted against your artwork.
  • Shelf life: 36 months. Stability data for the marketed pack is included in the dossier.
  • Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
  • Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.

Registration, Dossier & Tender Support

Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.

  • CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
  • Site Master File and GMP certificate for the manufacturing workshops.
  • Method validation, stability protocol and the shelf-life justification for the marketed pack.
  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.

This page describes Omeprazole 20mg Capsules as a product of the gastrointestinal and antiemetic medicines named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.

Frequently Asked Questions

What pack size is available for Omeprazole 20mg Capsules?

The reference pack is 10 capsules/blister*10/box. Non-standard blister, bottle and carton configurations are quoted against your artwork, matched to the stability data already held for the presentation.

What documentation comes with a shipment of Omeprazole 20mg Capsules?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months.

Does the batch documentation for Omeprazole 20mg Capsules support a registration filing?

Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Is omeprazole on the WHO Essential Medicines List?

Yes — section 17.1 lists omeprazole as powder for injection 40 mg in vial, powder for oral liquid and solid oral forms of 10, 20 and 40 mg.

Do you supply both ondansetron and metoclopramide?

Yes, as injectables and in oral form. Note the Model List age limits: metoclopramide is not for neonates, and ondansetron is listed above one month of age.

Related GI & Antiemetics Products

Browse the full GI & Antiemetics range; all Capsules; the complete product catalogue.

Request a Quotation for Omeprazole 20mg Capsules

Send the specification, pack size, quantity and destination market for Omeprazole 20mg Capsules 20mg and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products